Purple Biotech (PPBT) Cash & Current Investments (2014 - 2026)
Purple Biotech (PPBT) reported Cash & Current Investments of $6.4 million for Q1 2026, down 13.17% year-over-year from $7.4 million in Q1 2025, and down 32.88% on a QoQ basis from $9.6 million in Q4 2025.
Purple Biotech (PPBT) has 11 years of Cash & Current Investments data on file, last reported at $6.4 million in Q1 2026.
- Quarterly Cash & Current Investments fell 13.17% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 13.17% YoY) and the FY2025 annual result came in at $9.6 million, up 24.73% from the prior year.
- Cash & Current Investments eased to $6.4 million in Q1 2026 per PPBT's latest filing, from $9.6 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $15.5 million in Q4 2022 and bottomed at $6.4 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $8.6 million (2024), against an average of $10.2 million.
- The widest annual swing landed in 2022, when Cash & Current Investments plunged 67.24%; it then increased 24.73% in 2025.
- Tracing PPBT's Cash & Current Investments over 5 years: stood at $15.5 million in 2022, then fell by 5.81% to $14.6 million in 2023, then plunged by 47.29% to $7.7 million in 2024, then advanced by 24.73% to $9.6 million in 2025, then sank by 32.88% to $6.4 million in 2026.
- Per Business Quant, the three latest PPBT Cash & Current Investments figures stand at $6.4 million (Q1 2026), $9.6 million (Q4 2025), and $7.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 6.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 9.57 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Jun 30, 2025 | 5.59 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 6.29 Mn |
| Jun 30, 2024 | 7.37 Mn |
| Mar 31, 2024 | 10.83 Mn |
| Dec 31, 2023 | 15.34 Mn |
| Sep 30, 2023 | 15.95 Mn |
| Jun 30, 2023 | 18.05 Mn |
| Mar 31, 2023 | 22.73 Mn |
| Dec 31, 2022 | 15.46 Mn |
| Sep 30, 2022 | 33.08 Mn |
| Jun 30, 2022 | 32.90 Mn |
| Mar 31, 2022 | 39.55 Mn |
| Dec 31, 2021 | 47.20 Mn |
| Sep 30, 2021 | 47.69 Mn |
| Jun 30, 2021 | 48.39 Mn |
| Mar 31, 2021 | 55.45 Mn |
| Dec 31, 2020 | 57.81 Mn |
| Jun 30, 2020 | 63.01 Mn |
| Dec 31, 2019 | 6.39 Mn |
| Jun 30, 2019 | 7.82 Mn |
| Dec 31, 2018 | 6.68 Mn |
| Jun 30, 2018 | 11.83 Mn |
| Dec 31, 2017 | 7.44 Mn |
| Jun 30, 2017 | 14.36 Mn |
| Dec 31, 2016 | 14.66 Mn |
| Jun 30, 2016 | 15.06 Mn |
| Dec 31, 2015 | 10.70 Mn |
| Sep 30, 2015 | 981,000.00 |
| Dec 31, 2014 | 1.31 Mn |
| Sep 30, 2014 | 2.42 Mn |